Works by Gerstner, Elizabeth R.


Results: 43
    1
    2
    3
    4
    5
    6
    7
    8

    Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 8, p. 1219, doi. 10.1093/neuonc/noac086
    By:
    • Ellingson, Benjamin M;
    • Gerstner, Elizabeth R;
    • Lassman, Andrew B;
    • Chung, Caroline;
    • Colman, Howard;
    • Cole, Patricia E;
    • Leung, David;
    • Allen, Joshua E;
    • Ahluwalia, Manmeet S;
    • Boxerman, Jerrold;
    • Brown, Matthew;
    • Goldin, Jonathan;
    • Nduom, Edjah;
    • Hassan, Islam;
    • Gilbert, Mark R;
    • Mellinghoff, Ingo K;
    • Weller, Michael;
    • Chang, Susan;
    • Arons, David;
    • Meehan, Clair
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 12, p. 1822, doi. 10.1093/neuonc/noaa105
    By:
    • Huang, Raymond Y;
    • Young, Robert J;
    • Ellingson, Benjamin M;
    • Veeraraghavan, Harini;
    • Wang, Wei;
    • Tixier, Florent;
    • Um, Hyemin;
    • Nawaz, Rasheed;
    • Luks, Tracy;
    • Kim, John;
    • Gerstner, Elizabeth R;
    • Schiff, David;
    • Peters, Katherine B;
    • Mellinghoff, Ingo K;
    • Chang, Susan M;
    • Cloughesy, Timothy F;
    • Wen, Patrick Y
    Publication type:
    Article
    15

    Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 9, p. 1262, doi. 10.1093/neuonc/noaa141
    By:
    • Boxerman, Jerrold L;
    • Quarles, Chad C;
    • Hu, Leland S;
    • Erickson, Bradley J;
    • Gerstner, Elizabeth R;
    • Smits, Marion;
    • Kaufmann, Timothy J;
    • Barboriak, Daniel P;
    • Huang, Raymond H;
    • Wick, Wolfgang;
    • Weller, Michael;
    • Galanis, Evanthia;
    • Kalpathy-Cramer, Jayashree;
    • Shankar, Lalitha;
    • Jacobs, Paula;
    • Chung, Caroline;
    • Bent, Martin J van den;
    • Chang, Susan;
    • Yung, W K Al;
    • Cloughesy, Timothy F
    Publication type:
    Article
    16
    17
    18

    Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1038/s41598-018-34820-x
    By:
    • Ly, K. Ina;
    • Vakulenko-Lagun, Bella;
    • Emblem, Kyrre E.;
    • Ou, Yangming;
    • Da, Xiao;
    • Betensky, Rebecca A.;
    • Kalpathy-Cramer, Jayashree;
    • Duda, Dan G.;
    • Jain, Rakesh K.;
    • Chi, Andrew S.;
    • Plotkin, Scott R.;
    • Batchelor, Tracy T.;
    • Sorensen, Gregory;
    • Rosen, Bruce R.;
    • Gerstner, Elizabeth R.
    Publication type:
    Article
    19

    ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

    Published in:
    PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198548
    By:
    • Ratai, Eva-Maria;
    • Zhang, Zheng;
    • Fink, James;
    • Muzi, Mark;
    • Hanna, Lucy;
    • Greco, Erin;
    • Richards, Todd;
    • Kim, Daniel;
    • Andronesi, Ovidiu C.;
    • Mintz, Akiva;
    • Kostakoglu, Lale;
    • Prah, Melissa;
    • Ellingson, Benjamin;
    • Schmainda, Kathleen;
    • Sorensen, Gregory;
    • Barboriak, Daniel;
    • Mankoff, David;
    • Gerstner, Elizabeth R.;
    • null, null
    Publication type:
    Article
    20

    NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.

    Published in:
    2020
    By:
    • Lee, Eudocia Q.;
    • Zhang, Peixin;
    • Wen, Patrick Y.;
    • Gerstner, Elizabeth R.;
    • Reardon, David A.;
    • Aldape, Kenneth D.;
    • deGroot, John F.;
    • Pan, Edward;
    • Raizer, Jeffrey J.;
    • Kim, Lyndon J.;
    • Chmura, Steven J.;
    • Robins, H. Ian;
    • Connelly, Jennifer M.;
    • Battiste, James D.;
    • Villano, John L.;
    • Wagle, Naveed;
    • Merrell, Ryan T.;
    • Wendland, Merideth M.;
    • Mehta, Minesh P.
    Publication type:
    journal article
    21
    22

    Glioblastoma care in the elderly.

    Published in:
    2016
    By:
    • Jordan, Justin T.;
    • Gerstner, Elizabeth R.;
    • Batchelor, Tracy T.;
    • Cahill, Daniel P.;
    • Plotkin, Scott R.
    Publication type:
    journal article
    23

    The Role of Antibody-Based Therapies in Neuro-Oncology.

    Published in:
    Antibodies (2073-4468), 2023, v. 12, n. 4, p. 74, doi. 10.3390/antib12040074
    By:
    • Ramapriyan, Rishab;
    • Sun, Jing;
    • Curry, Annabel;
    • Richardson, Leland G.;
    • Ramesh, Tarun;
    • Gaffey, Matthew A.;
    • Gedeon, Patrick C.;
    • Gerstner, Elizabeth R.;
    • Curry, William T.;
    • Choi, Bryan D.
    Publication type:
    Article
    24
    25
    26

    Regional healthy brain activity, glioma occurrence and symptomatology.

    Published in:
    2022
    By:
    • Numan, Tianne;
    • Breedt, Lucas C;
    • Maciel, Bernardo de A P C;
    • Kulik, Shanna D;
    • Derks, Jolanda;
    • Schoonheim, Menno M;
    • Klein, Martin;
    • Hamer, Philip C de Witt;
    • Miller, Julie J;
    • Gerstner, Elizabeth R;
    • Stufflebeam, Steven M;
    • Hillebrand, Arjan;
    • Stam, Cornelis J;
    • Geurts, Jeroen J G;
    • Reijneveld, Jaap C;
    • Douw, Linda;
    • de Witt Hamer, Philip C
    Publication type:
    journal article
    27
    28
    29
    30

    Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdac185
    By:
    • Schmidts, Andrea;
    • Srivastava, Ambike A;
    • Ramapriyan, Rishab;
    • Bailey, Stefanie R;
    • Bouffard, Amanda A;
    • Cahill, Daniel P;
    • Carter, Bob S;
    • Curry, William T;
    • Dunn, Gavin P;
    • Frigault, Matthew J;
    • Gerstner, Elizabeth R;
    • Ghannam, Jack Y;
    • Kann, Michael C;
    • Larson, Rebecca C;
    • Leick, Mark B;
    • Nahed, Brian V;
    • Richardson, Leland G;
    • Scarfò, Irene;
    • Sun, Jing;
    • Wakimoto, Hiroaki
    Publication type:
    Article
    31

    Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac128
    By:
    • El-Abtah, Mohamed E.;
    • Talati, Pratik;
    • Fu, Melanie;
    • Chun, Benjamin;
    • Clark, Patrick;
    • Peters, Anna;
    • Ranasinghe, Anthony;
    • He, Julian;
    • Rapalino, Otto;
    • Batchelor, Tracy T.;
    • Gonzalez, R. Gilberto;
    • Curry, William T.;
    • Dietrich, Jorg;
    • Gerstner, Elizabeth R.;
    • Ratai, Eva-Maria
    Publication type:
    Article
    32
    33
    34
    35

    Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 4, p. 546, doi. 10.1093/neuonc/nox161
    By:
    • Galanis, Evanthia;
    • Anderson, S. Keith;
    • Miller, C. Ryan;
    • Sarkaria, Jann N.;
    • Jaeckle, Kurt;
    • Buckner, Jan C.;
    • Ligon, Keith L.;
    • Ballman, Karla V.;
    • Moore Jr., Dennis F.;
    • Nebozhyn, Michael;
    • Loboda, Andrey;
    • Schiff, David;
    • Ahluwalia, Manmeet Singh;
    • Lee, Eudocia Q.;
    • Gerstner, Elizabeth R.;
    • Lesser, Glenn J.;
    • Prados, Michael;
    • Grossman, Stuart A.;
    • Cerhan, Jane;
    • Giannini, Caterina
    Publication type:
    Article
    36
    37
    38
    39
    40

    INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii12, doi. 10.1093/neuonc/nou206.42
    By:
    • Batchelor, Tracy T.;
    • Gerstner, Elizabeth R.;
    • Emblem, Kyrre E.;
    • Duda, Dan G.;
    • Kalpathy-Cramer, Jayashree;
    • Snuderl, Matija;
    • Ancukiewicz, Marek;
    • Polaskova, Pavlina;
    • Pinho, Marco C.;
    • Jennings, Dominique;
    • Plotkin, Scott R.;
    • Chi, Andrew S.;
    • Eichler, April F.;
    • Dietrich, Jorg;
    • Hochberg, Fred H.;
    • Lu-Emerson, Christine;
    • Iafrate, A. John;
    • Ivy, S. Percy;
    • Rosen, Bruce;
    • Loeffler, Jay S.
    Publication type:
    Article
    41

    Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.

    Published in:
    Neuro-Oncology, 2013, v. 15, n. 8, p. 1079, doi. 10.1093/neuonc/not082
    By:
    • Lu-Emerson, Christine;
    • Snuderl, Matija;
    • Kirkpatrick, Nathaniel D.;
    • Goveia, Jermaine;
    • Davidson, Christian;
    • Huang, Yuhui;
    • Riedemann, Lars;
    • Taylor, Jennie;
    • Ivy, Percy;
    • Duda, Dan G.;
    • Ancukiewicz, Marek;
    • Plotkin, Scott R.;
    • Chi, Andrew S.;
    • Gerstner, Elizabeth R.;
    • Eichler, April F.;
    • Dietrich, Jorg;
    • Stemmer-Rachamimov, Anat O.;
    • Batchelor, Tracy T.;
    • Jain, Rakesh K.
    Publication type:
    Article
    42
    43